Oxford Asset Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-6,701
| Closed | -$940K | – | 2039 |
|
2019
Q3 | $940K | Buy |
+6,701
| New | +$940K | 0.02% | 975 |
|
2018
Q4 | – | Sell |
-15,251
| Closed | -$2.13M | – | 2058 |
|
2018
Q3 | $2.13M | Buy |
+15,251
| New | +$2.13M | 0.04% | 629 |
|
2018
Q1 | – | Sell |
-5,805
| Closed | -$965K | – | 1853 |
|
2017
Q4 | $965K | Buy |
+5,805
| New | +$965K | 0.02% | 955 |
|
2017
Q2 | – | Sell |
-14,014
| Closed | -$996K | – | 1671 |
|
2017
Q1 | $996K | Sell |
14,014
-31,590
| -69% | -$2.25M | 0.02% | 805 |
|
2016
Q4 | $2.33M | Buy |
45,604
+8,156
| +22% | +$417K | 0.08% | 281 |
|
2016
Q3 | $1.72M | Sell |
37,448
-135,037
| -78% | -$6.22M | 0.05% | 427 |
|
2016
Q2 | $5.2M | Buy |
+172,485
| New | +$5.2M | 0.17% | 138 |
|
2016
Q1 | – | Sell |
-115,936
| Closed | -$6.75M | – | 884 |
|
2015
Q4 | $6.75M | Buy |
+115,936
| New | +$6.75M | 0.16% | 134 |
|